June 30, 2023 Big biotech's upcoming clinical priorities Key catalysts lie ahead for Amgen, Argenx, Point Biopharma and Novo Nordisk.
September 30, 2020 Clinical data focus for the smallest players Our final look at upcoming catalysts sees data expected from Replimune, TCR2 Therapeutics, Anavex and more.
